Enzon Pharmaceuticals, Inc. (ENZN)

CAPS Rating:

A biopharmaceutical company dedicated to the development and commercialization of therapeutics to treat patients with cancer and adjacent diseases.

View Ticker Page (ENZN)

Results 1 - 10 of 10 : 1

Recs

0

Avatar MadisonClub1 (< 20) Submitted: 11/22/06 8:11 PM : Start Price: $8.35 ENZN Score: 6.05

All looks bad for it but ....just a feeling

Report this Post Replies: 0 | Reply | Permalink

Recs

0

Avatar hennessy7 (< 20) Submitted: 5/26/08 9:12 AM : Start Price: $8.85 ENZN Score: 1.00

I like the sector. This is a sector pick as I have done little DD on this stock. I think small biotech has been hit hard, and the cancer market, in particular, is going to turn around. Plus, I do not see too many incredible investments in other se...

Report this Post Replies: 0 | Reply | Permalink

Recs

0

Avatar WonderWolf (74.90) Submitted: 5/20/08 11:48 PM : Start Price: $8.88 ENZN Score: 2.60

Working on 2 cancer drugs and will be the big winner!!

Report this Post Replies: 0 | Reply | Permalink

Recs

0

Avatar Addgirl48 (31.83) Submitted: 3/29/08 11:21 AM : Start Price: $9.28 ENZN Score: -5.25

People all ways needing pills so Pharmaceuticals all ways geting business and all ways will

Report this Post Replies: 0 | Reply | Permalink

Recs

0

Avatar djinsanity (87.44) Submitted: 2/09/08 12:17 PM : Start Price: $8.14 ENZN Score: 4.44

PEG-SN38 showed anti-tumor activity in resistant pre-clinical models, FDA approval for DepoCyt, leader in stem cell research, I can see it doing phenomenal

Report this Post Replies: 0 | Reply | Permalink

Recs

0

Avatar zzlangerhans (99.34) Submitted: 11/12/07 10:28 AM : Start Price: $9.89 ENZN Score: -2.47

The company sold a 25% interest in PEG-intron for 93M, therefore the remaining royalty interest in PEG-intron alone should be worth 280M, which is close to the enterprise value of the company. That would value the rest of the revenue stream as well a...

Report this Post Replies: 0 | Reply | Permalink